Angelo C. Camilli
Araraquara, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Pharmacological Modulation of Nrf2 Signaling Regulates Oxidative Stress, Inflammation, and Alveolar Bone Loss in Experimental Periodontitis.
Journal: Journal of periodontal research
Published: April 28, 2026
JAK Inhibition Prevents Bone Loss and Reduces Inflammation in Experimental Periodontitis.
Journal: Journal of periodontal research
Published: March 28, 2025
Understanding the peroxisome proliferator-activated receptor gamma (PPAR-γ) role in periodontitis and diabetes mellitus: A molecular perspective.
Journal: Biochemical pharmacology
Published: December 12, 2024
Local Application of a New Chalconic Derivative (Chalcone T4) Reduces Inflammation and Oxidative Stress in a Periodontitis Model in Rats.
Journal: Antioxidants (Basel, Switzerland)
Published: August 15, 2024
JAK/STAT as a Potential Therapeutic Target for Osteolytic Diseases.
Journal: International journal of molecular sciences
Published: April 20, 2023
Local administration of curcumin-loaded nanoparticles enhances periodontal repair in vivo.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: May 26, 2022
Chalcone T4, a novel chalconic compound, inhibits inflammatory bone resorption in vivo and suppresses osteoclastogenesis in vitro.
Journal: Journal of periodontal research
Published: August 14, 2020
Silencing matrix metalloproteinase-13 (Mmp-13) reduces inflammatory bone resorption associated with LPS-induced periodontal disease in vivo.
Journal: Clinical oral investigations
Published: May 20, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026